Pazár Borbála, Ea Hang-Korng, Narayan Sharmal, Kolly Laeticia, Bagnoud Nathalie, Chobaz Véronique, Roger Thierry, Lioté Frédéric, So Alexander, Busso Nathalie
Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland.
J Immunol. 2011 Feb 15;186(4):2495-502. doi: 10.4049/jimmunol.1001284. Epub 2011 Jan 14.
Basic calcium phosphate (BCP) crystals are associated with severe osteoarthritis and acute periarticular inflammation. Three main forms of BCP crystals have been identified from pathological tissues: octacalcium phosphate, carbonate-substituted apatite, and hydroxyapatite. We investigated the proinflammatory effects of these BCP crystals in vitro with special regard to the involvement of the NLRP3-inflammasome in THP-1 cells, primary human monocytes and macrophages, and mouse bone marrow-derived macrophages (BMDM). THP-1 cells stimulated with BCP crystals produced IL-1β in a dose-dependent manner. Similarly, primary human cells and BMDM from wild-type mice also produced high concentrations of IL-1β after crystal stimulation. THP-1 cells transfected with short hairpin RNA against the components of the NLRP3 inflammasome and mouse BMDM from mice deficient for NLRP3, apoptosis-associated speck-like protein, or caspase-1 did not produce IL-1β after BCP crystal stimulation. BCP crystals induced macrophage apoptosis/necrosis as demonstrated by MTT and flow cytometric analysis. Collectively, these results demonstrate that BCP crystals induce IL-1β secretion through activating the NLRP3 inflammasome. Furthermore, we speculate that IL-1 blockade could be a novel strategy to inhibit BCP-induced inflammation in human disease.
碱性磷酸钙(BCP)晶体与严重骨关节炎和急性关节周围炎症相关。已从病理组织中鉴定出BCP晶体的三种主要形式:磷酸八钙、碳酸取代磷灰石和羟基磷灰石。我们在体外研究了这些BCP晶体的促炎作用,特别关注NLRP3炎性小体在THP-1细胞、原代人单核细胞和巨噬细胞以及小鼠骨髓来源巨噬细胞(BMDM)中的作用。用BCP晶体刺激的THP-1细胞以剂量依赖的方式产生IL-1β。同样,来自野生型小鼠的原代人细胞和BMDM在晶体刺激后也产生高浓度的IL-1β。用针对NLRP3炎性小体成分的短发夹RNA转染的THP-1细胞以及来自NLRP3、凋亡相关斑点样蛋白或caspase-1缺陷小鼠的小鼠BMDM在BCP晶体刺激后不产生IL-1β。MTT和流式细胞术分析表明,BCP晶体诱导巨噬细胞凋亡/坏死。总体而言,这些结果表明BCP晶体通过激活NLRP3炎性小体诱导IL-1β分泌。此外,我们推测IL-1阻断可能是抑制人类疾病中BCP诱导炎症的一种新策略。